Appointment booking for Dr. Christopher Parot, OD is currently not available.Dr. Christopher Parot, OD has not yet fully activated their profile on DiabetesIQ.
Dr. Christopher Parot, OD (he/him) is a Optometrist in Peoria, AZ with over 17 years of experience. What is your opinion of Dr. Christopher Parot, OD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Christopher Parot, OD has received over $7,977 which includes payments from the following companies:
$1,873.36 from CooperVision Inc.
$1,872.02 from OPTOS, INC.
$886.97 from OPTOS PLC
$507.80 from Bausch & Lomb, a division of Bausch Health US, LLC
$490.18 from Alcon Laboratories Inc
$489.32 from Valeant Pharmaceuticals North America LLC
$370.32 from Visioneering Technologies, Inc.
$322.08 from MacuLogix, Inc.
$214.08 from OPTOVUE, INC.
$203.86 from Johnson & Johnson Vision Care, Inc.
$184.59 from Carl Zeiss Meditec, Inc.
$143.57 from Allergan Inc.
$123.93 from Abbott Laboratories
$121.79 from GLAUKOS CORPORATION
$118.88 from Sight Sciences, Inc.
$24.87 from Aerie Pharmaceuticals, Inc.
$17.20 from Carl Zeiss Meditec AG
$12.39 from Shire North American Group Inc
Payments received by Dr. Christopher Parot, OD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!